CnidicinCAS# 14348-21-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 14348-21-1 | SDF | Download SDF |
| PubChem ID | 10043694 | Appearance | Powder |
| Formula | C21H22O5 | M.Wt | 354.40 |
| Type of Compound | Coumarins | Storage | Desiccate at -20°C |
| Synonyms | Kinidilin; Knidicin | ||
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 4,9-bis(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one | ||
| SMILES | CC(=CCOC1=C2C=COC2=C(C3=C1C=CC(=O)O3)OCC=C(C)C)C | ||
| Standard InChIKey | HJMDOAWWVCOEDW-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C21H22O5/c1-13(2)7-10-23-18-15-5-6-17(22)26-20(15)21(25-11-8-14(3)4)19-16(18)9-12-24-19/h5-9,12H,10-11H2,1-4H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cnidicin exhibits a significant inhibition on the proliferation of cultured human tumor cells such as A549 (non small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nervous system) and HCT-15 (colon) in vitro . 2. Cnidicin has anti-allergic and anti-inflammatory activity, it inhibits the degranulation of mast cell and the NO generation in RAW 264.7 cells(IC50 value, 7.5 microM). |
| Targets | NO | NOS |
Cnidicin Dilution Calculator
Cnidicin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.8217 mL | 14.1084 mL | 28.2167 mL | 56.4334 mL | 70.5418 mL |
| 5 mM | 0.5643 mL | 2.8217 mL | 5.6433 mL | 11.2867 mL | 14.1084 mL |
| 10 mM | 0.2822 mL | 1.4108 mL | 2.8217 mL | 5.6433 mL | 7.0542 mL |
| 50 mM | 0.0564 mL | 0.2822 mL | 0.5643 mL | 1.1287 mL | 1.4108 mL |
| 100 mM | 0.0282 mL | 0.1411 mL | 0.2822 mL | 0.5643 mL | 0.7054 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lucidenic acid B
Catalog No.:BCN8607
CAS No.:95311-95-8
- Toringin
Catalog No.:BCN8606
CAS No.:1329-10-8
- Saikosaponin I
Catalog No.:BCN8605
CAS No.:103629-71-6
- Uvarigranol C
Catalog No.:BCN8604
CAS No.:172104-04-0
- 9-Methymyrrhone
Catalog No.:BCN8603
CAS No.:1809980-22-0
- Asperosaponin IV
Catalog No.:BCN8602
CAS No.:126778-93-6
- Rubipodanone A
Catalog No.:BCN8601
CAS No.:2170211-22-8
- Astraganoside
Catalog No.:BCN8600
CAS No.:1011711-05-9
- Isoastragaloside IV
Catalog No.:BCN8599
CAS No.:136033-55-1
- Eriosematin
Catalog No.:BCN8598
CAS No.:168010-17-1
- Licoflavone A
Catalog No.:BCN8597
CAS No.:61153-77-3
- Dehydronuciferine
Catalog No.:BCN8596
CAS No.:7630-74-2
- Gambogellic acid
Catalog No.:BCN8609
CAS No.:173867-04-4
- Protodeltonin
Catalog No.:BCN8611
CAS No.:94992-08-2
- Licoarylcoumarin
Catalog No.:BCN8612
CAS No.:125709-31-1
- Pratensein 7-O-glucopyranoside
Catalog No.:BCN8613
CAS No.:36191-03-4
- Plantainoside D
Catalog No.:BCN8614
CAS No.:147331-98-4
- Suspenoidside B
Catalog No.:BCN8615
CAS No.:2161432-08-0
- 7beta-Hydroxybufalin
Catalog No.:BCN8616
CAS No.:20143-97-9
- 6'-O-Cinnamoylharpagide
Catalog No.:BCN8617
CAS No.:1245572-24-0
- 3,4,4a,9,10,10a-heexahydro-8-hydroxy-1-(hydroxymethyl)-1,4a-dimethyl-7-(1-methylethyl)-phenanthrene-2(1H)-one
Catalog No.:BCN8618
CAS No.:262599-12-2
- Sargentol
Catalog No.:BCN8619
CAS No.:623928-18-7
- Onjisaponin Z
Catalog No.:BCN8620
CAS No.:1078708-72-1
- Periplocoside M
Catalog No.:BCN8621
CAS No.:116782-73-1
Cnidicin, a coumarin, from the root of Angelica koreana, inhibits the degranulation of mast cell and the NO generation in RAW 264.7 cells.[Pubmed:11301870]
Planta Med. 2001 Mar;67(2):172-4.
Cnidicin (1) and five related coumarins were isolated from the root extract of Angelica koreana (Umbelliferae) as active principles responsible for the inhibitory effect on the degranulation process of cultured mast cells. Cnidicin (1) demonstrated a significant inhibition upon the release of beta-hexosaminidase from the cultured RBL-2H3 cells in a dose dependent manner (IC50 value, 25 microM) and upon the nitric oxide production from the activated RAW264.7 cells (IC50 value, 7.5 microM). In agreement with this, Cnidicin inhibited the expression of nitric oxide synthase in RAW264.7 cells.
Antiproliferative effect of furanocoumarins from the root of Angelica dahurica on cultured human tumor cell lines.[Pubmed:17143927]
Phytother Res. 2007 Mar;21(3):288-90.
A bioassay-guided fractionation of the root extract of Angelica dahurica (Umbelliferae) led to the isolation of six furanocoumarins as active ingredients responsible for the antitumoral property. The hexane soluble part of the extract demonstrated a significant inhibition on the proliferation of cultured human tumor cells such as A549 (non small cell lung), SK-OV-3 (ovary), SK-MEL-2 (melanoma), XF498 (central nervous system) and HCT-15 (colon) in vitro, whereas the remaining water soluble part exhibited poor inhibition. Intensive investigation of the hexane soluble part of the extract yielded six furanocoumarins, i.e. isoimperatorin, Cnidicin, imperatorin, oxypeucedanin, byakangelicol, oxypeucedanin hydrate, all of which exhibited a significant inhibition on cell proliferation in a dose-dependent manner.
